How MiniMed Group, Inc. stacks up

MMED · against 224 other Healthcare companies of similar size

Overall

50/ 100

Below the middle of the pack.

Ranked #141 of 225 · scores higher than 36% of peers

Bars: peers in each 10-point band of the overall score

53 peers with an overall score of 50–59, including MMED · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#136 of 228Score 45 / 100 · beats 41%Growth#86 of 206Score 66 / 100 · beats 58%Profitability#167 of 225Score 31 / 100 · beats 25%Risk#88 of 226Moderate relative risk · safety 60 · beats 61%

Ranking by overall score

Top 5 and the companies ranked around MMED

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	BB Biotech AGBBZA.DE · Europe	3.1B EUR (≈$3.4B)	100		100	100	0 / 2
2	RemeGen Co., Ltd.9995.HK · Hong Kong	37.3B HKD (≈$4.8B)	90	99	98	84	0 / 2
3	Nurix Therapeutics, Inc.NRIX · US-listed	2.7B USD	84	75	98	99	1 / 2
4	Bavarian Nordic A/SBAVA.CO · Europe	18.3B DKK (≈$2.7B)	81	86	74	86	0 / 2
5	Asahi Intecc Co., Ltd.7747.T · Japan	936.1B JPY (≈$6.4B)	80	65	86	94	0 / 2
⋯
135	Viridian Therapeutics, Inc.VRDN · US-listed	2.8B USD	51	8	99	7	0 / 2
141	Eisai Co., Ltd.4523.T · Japan	1.42T JPY (≈$9.6B)	50	65	34	54	1 / 2
141	Aveanna Healthcare Holdings Inc.AVAH · US-listed	2.9B USD	50	57	75	66	2 / 2
141	Beam Therapeutics Inc.BEAM · US-listed	2.7B USD	50	8	92	14	0 / 2
141	MiniMed Group, Inc.MMED · US-listed	5.3B USD	50	45	66	31	1 / 2
141	Spyre Therapeutics, Inc.SYRE · US-listed	8.8B USD	50	33	—	24	0 / 2
146	Suzhou Zelgen Biopharmaceuticals Co., Ltd.688266.SS · China	22.1B CNY (≈$3.1B)	49	49	93	19	1 / 2
146	Convatec Group PLCCTEC.L · United Kingdom	4.7B GBP (≈$6.1B)	49	62	43	74	2 / 2
146	DiaSorin S.p.A.DIA.MI · Europe	4.0B EUR (≈$4.4B)	49	68	23	76	2 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…